Reflecting on my career and the significant societal and technological shifts during those years, I see it as split between two generations, each…

This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations for the Development of Drugs…

I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and expectations: the smart ones, the…

In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated innovation, and a…

There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your…

“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective luddites.” That’s how…

When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are…

When I moved to Boston over thirty years ago, I had never even heard of the Boston Marathon. I grew up in the Midwest and moved to the West Coast for…

We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as this topic is very much a part of…

Historically, biopharma companies developed drugs for patients with an illness — but the illness was the primary focus. In recent years, much has…